Trial finds vitamin D supplements don't reduce COVID severity but could reduce long COVID risk

medicalxpress - In a large, randomized trial, researchers at Mass General Brigham found that high-dose vitamin D3 did not reduce COVID-19 infection severity, but may impact long COVID outcomes. Results of the study are published in The Journal of Nutrition.

AI Summary: A large randomized trial found high‑dose vitamin D3 did not lower acute COVID‑19 severity but revealed a surprising signal: supplementation may reduce the risk of developing long‑COVID. The result complicates the vitamin D narrative — not a cure, perhaps a modest shield against persistent post‑infectious symptoms worthy of further investigation.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

Daily oral care more than halves hospital‑acquired pneumonia risk / 5 wks

Gut microbe tied to Mediterranean diet boosts muscle strength in mice / 2 months

‘Oslo patient’ reaches HIV remission after rare stem‑cell transplant / 6 wks

Antiviral ensitrelvir dramatically cuts household COVID transmission risk / 15 days

The peptide problem: Hype outruns evidence, researchers caution / 22 days

WHO approves first malaria treatment for infants; Novartis drug prequalified / 5 wks

Sleep and diet may protect against chronic stress better than exercise / 15 days